MiSight 1 day is the first and only FDA-approved product that’s clinically proven to slow myopia progression.
Three year peer-reviewed results indicated that the use of MiSight 1 day was shown to slow myopia progression: 59% as measured by mean cycloplegic spherical equivalent, and 52% as measured by mean axial elongation of the eye.
Contact: [email protected]
